Danielle Hobbs

Danielle Hobbs is an accomplished executive with extensive experience in corporate communications and healthcare. Currently serving as Executive Vice President of Corporate Communications at Syncromune®, Danielle has played a crucial role in advancing the company's innovative in situ therapy for metastatic cancers since December 2020. At Brigham and Women's Hospital, Danielle is the Co-Chair of the Emergency Medicine Advisory Board. As President of Medevixx, founded in 2005, Danielle identified and addressed training deficiencies in the medical device industry. Previous leadership roles include Chief Operating Officer at Summa Therapeutics, where Danielle contributed to the development of advanced angioplasty technologies, and Vice President of Marketing & Communications at ImmunSYS, focusing on cancer immunotherapy products. Danielle also co-founded Capture Vascular and held significant positions at AngioDynamics and Forest Laboratories, where a strong foundation in sales and training was established. Danielle holds a Bachelor’s degree in Physiology and Pre-Med from Ohio University.